132 related articles for article (PubMed ID: 29082750)
1. Assessment of Adherence to Baseline Quality Measures for Cirrhosis and the Impact of Performance Feedback in a Regional VA Medical Center.
Cahill JA; Rizvi S; Saeian K
Am J Med Qual; 2018; 33(3):262-268. PubMed ID: 29082750
[TBL] [Abstract][Full Text] [Related]
2. Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems.
Sclair SN; Carrasquillo O; Czul F; Trivella JP; Li H; Jeffers L; Martin P
Dig Dis Sci; 2016 Oct; 61(10):2857-2867. PubMed ID: 27289585
[TBL] [Abstract][Full Text] [Related]
3. Performance Feedback Improves Compliance With Quality Measures.
Loy V; Kwiatt J; Dodda A; Martin E; Dua A; Saeian K
Am J Med Qual; 2016; 31(2):118-24. PubMed ID: 25348546
[TBL] [Abstract][Full Text] [Related]
4. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.
Wong CR; Garcia RT; Trinh HN; Lam KD; Ha NB; Nguyen HA; Nguyen KK; Levitt BS; Nguyen MH
Dig Dis Sci; 2009 Dec; 54(12):2712-21. PubMed ID: 19876735
[TBL] [Abstract][Full Text] [Related]
5. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
[TBL] [Abstract][Full Text] [Related]
6. Development of hepatocellular carcinoma after successful management of esophageal variceal bleeding.
Chen WC; Lo GH; Lai KH; Cheng JS; Hsu PI; Lin CK
J Chin Med Assoc; 2004 Nov; 67(11):557-64. PubMed ID: 15720069
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of High-Dose, Rapid, Hepatitis A and B Vaccination Schedules in Patients With Cirrhosis.
Wigg AJ; Wundke R; McCormick R; Muller KR; Ramachandran J; Narayana SK; Woodman RJ
Clin Gastroenterol Hepatol; 2019 May; 17(6):1210-1212.e1. PubMed ID: 30144521
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular Carcinoma Surveillance Among Cirrhotic Patients With Commercial Health Insurance.
Goldberg DS; Valderrama A; Kamalakar R; Sansgiry SS; Babajanyan S; Lewis JD
J Clin Gastroenterol; 2016 Mar; 50(3):258-65. PubMed ID: 26352107
[TBL] [Abstract][Full Text] [Related]
9. [Variable clinical symptoms of hepatocellular carcinoma].
Struve C; Heusermann U
Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
[TBL] [Abstract][Full Text] [Related]
10. [Screening for hepatocellular carcinoma].
Leone N; Rizzetto M
Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
[TBL] [Abstract][Full Text] [Related]
11. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
[TBL] [Abstract][Full Text] [Related]
12. The quality of care provided to patients with varices in the department of Veterans Affairs.
Buchanan PM; Kramer JR; El-Serag HB; Asch SM; Assioun Y; Bacon BR; Kanwal F
Am J Gastroenterol; 2014 Jul; 109(7):934-40. PubMed ID: 24989087
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
14. Esophageal varices are not predictive of patient prognosis after surgical resection of hepatocellular carcinoma.
Chang CY; Hsieh WY; Chau GY; Chen PH; Su CW; Hou MC; Lei HJ; Huo TI; Huang YH; Lin HC; Wu JC
Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1368-1377. PubMed ID: 29994873
[TBL] [Abstract][Full Text] [Related]
15. Screening for hepatocellular carcinoma in patients with advanced cirrhosis.
Chalasani N; Horlander JC; Said A; Hoen H; Kopecky KK; Stockberger SM; Manam R; Kwo PY; Lumeng L
Am J Gastroenterol; 1999 Oct; 94(10):2988-93. PubMed ID: 10520857
[TBL] [Abstract][Full Text] [Related]
16. Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA.
Flemming JA; Saxena V; Shen H; Terrault NA; Rongey C
Dig Dis Sci; 2016 Jan; 61(1):62-9. PubMed ID: 26363933
[TBL] [Abstract][Full Text] [Related]
17. Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.
Hearn B; Chasan R; Bichoupan K; Suprun M; Bagiella E; Dieterich DT; Perumalswami P; Branch AD; Huprikar S
Clin Infect Dis; 2015 Dec; 61(11):1742-8. PubMed ID: 26240206
[TBL] [Abstract][Full Text] [Related]
18. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
[TBL] [Abstract][Full Text] [Related]
19. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
Su TH; Hu TH; Chen CY; Huang YH; Chuang WL; Lin CC; Wang CC; Su WW; Chen MY; Peng CY; Chien RN; Huang YW; Wang HY; Lin CL; Yang SS; Chen TM; Mo LR; Hsu SJ; Tseng KC; Hsieh TY; Suk FM; Hu CT; Bair MJ; Liang CC; Lei YC; Tseng TC; Chen CL; Kao JH;
Liver Int; 2016 Dec; 36(12):1755-1764. PubMed ID: 27634134
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma screening practices in the Department of Veterans Affairs: findings from a national facility survey.
El-Serag HB; Alsarraj A; Richardson P; Davila JA; Kramer JR; Durfee J; Kanwal F
Dig Dis Sci; 2013 Nov; 58(11):3117-26. PubMed ID: 23868438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
